Navigation Links
Imaging gives clearer picture of cancer drugs' chances of success
Date:4/28/2014

The quest for new cancer treatments could be revolutionised by advances in technology that can visualise living cells and tissues, scientists claim.

Leading edge imaging techniques will make it easier to identify which are the most promising new drugs to take forward for patient testing, a review of the technology suggests.

Applying such techniques early in the drug discovery process could improve the success rate of new medicines by helping to rule out drugs that are unlikely to work.

Researchers at the University of Edinburgh are leading the way in using biological imaging to make the development of new cancer treatments more efficient.

Recent advances mean that scientists can now check how experimental drugs are working inside living cells and in real time.

Using automated microscopes to track fluorescent dyes, researchers can rapidly test thousands of potential drugs in different cancer cell types to find the most promising new treatments.

This pioneering approach known as phenotypic drug discovery monitors the effect of a trial drug on the disease as a whole rather than its impact on an individual target protein, which has been the approach until now.

Writing in the journal Nature Reviews Cancer, scientists argue that the new technologies will help to better predict how a drug will work in real life, not just in the test tube.

Currently, just five per cent of drugs tested in clinical trials are approved as therapies for patients. Often drugs do not work in a person as they do in an artificial environment. Sometimes treatments have unexpected side effects that are only picked up in the later stages of the development process.

Report author Dr Neil Carragher, of the Edinburgh Cancer Research UK Centre at the University of Edinburgh, said: "The drug discovery process is hugely expensive and inefficient. In Edinburgh we are leading the way in using biological imaging t
'/>"/>

Contact: Jen Middleton
jen.middleton@ed.ac.uk
44-131-650-6514
University of Edinburgh
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Neuroimaging: Live from inside the cell
2. Live cell imaging reveals distinct alterations of subcellular glutathione potentials
3. Tumors light up with new, unique imaging system using scorpion venom protein and a laser
4. Using susceptibility-weighted imaging to study concussion in college ice hockey players
5. A silk coat for diamonds makes sleek new imaging and drug delivery tool
6. New biomedical diagnostics using personalized 3-D imaging
7. North Shore-LIJ Completes Last Phase of $50M Upgrade of its Diagnostic Imaging Systems, $12M for GE Low-Dose CT Scanners to Reduce Patients’ Radiation Exposure
8. Olea Medical® Receives FDA 510(k) Clearance for Olea Sphere v2.3 Medical Imaging Software
9. Chemical imaging brings cancer tissue analysis into the digital age
10. Thermal Imaging Market (Solutions & Applications) Worth $5.84 Billion by 2018 - New Report by MarketsandMarkets
11. Pre-Clinical Imaging (In Vivo) Market worth $1.55 Billion by 2017 - New Report by MarketsandMarkets
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Imaging gives clearer picture of cancer drugs' chances of success
(Date:3/3/2015)... 03, 2015 The North ... to grow from $1,224.6 million to $1,694.6 ... 2014 and 2019. , Browse through the ... market for an analysis of industry trends ... tables and figures., http://www.micromarketmonitor.com/market/north-america-application-delivery-network-adn-7381582251.html , ...
(Date:3/3/2015)... March 03, 2015 Dallas plastic ... chairman of the upcoming Dallas Rhinoplasty Symposium, to be ... day symposium, which is attended by plastic surgeons and ... surgeons with detailed information on current topics, emerging techniques, ... rhinoplasty surgery . , The symposium will cover ...
(Date:3/3/2015)... San Jose, CA (PRWEB) March 03, 2015 ... cross-device computing and collaboration, announces Mirroring360 is now available ... Available for download from the Moverio Apps Market ... redirect their mobile device experience to the Epson Moverio ... empowering new usage models. , The Epson ...
(Date:3/3/2015)... 03, 2015 Birth Boot Camp ... they now have over 130 certified instructors in more ... Germany. In addition, the company recently launched a new ... childbirth educator certification program . Birth Boot Camp is ... birth partner. The practical information can be used by ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 OncLive® ... Center have joined forces to share news about ... today. The collaboration is part of OncLive’s Strategic ... alliance, OncLive’s editorial and marketing teams will partner ... Cancer Institute-designated cancer center, to highlight accomplishments. They ...
Breaking Medicine News(10 mins):Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 2Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 3Health News:Dr. Rod Rohrich to Chair 32nd Annual Dallas Rhinoplasty Symposium 2Health News:Dr. Rod Rohrich to Chair 32nd Annual Dallas Rhinoplasty Symposium 3Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 2Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 3Health News:Expectant Couples Worldwide Can Now Receive Training and Education in Natural Childbirth and Breastfeeding from Birth Boot Camp 2Health News:IU Simon Cancer Center Teams with OncLive® in Strategic Alliance Partnership 2Health News:IU Simon Cancer Center Teams with OncLive® in Strategic Alliance Partnership 3
... especially migraines, are more likely to be depressed,// feel ... symptoms, according to a study. ,The study involved ... the women surveyed, 593 reported episodic headache (fewer than ... (more than 15 headaches per month). Ninety percent of ...
... maximal therapy with minimal side effects - Scientists of ... School,// Greece, has been awarded a grant from the ... validation of new therapeutic strategies for cancer. ... activate a protein at the surface of ovarian, lung ...
... People suffering from muscular dystrophy should avoid over exercising, ... the arms or legs after exercise can be caused ... Germany Professional Association of Neurologists. ,Muscular dystrophy is ... over 30 forms of the condition have been identified. ...
... It sounds like something out of a very scary science ... tackled.// , A leading vet of Britain is ... the seasonal flu. ,Fred Landeg, deputy chief veterinary officer ... vets and farm workers before this year’s flu season. This ...
... cleft lip/palate faces predisposing factors to acquiring dental ... and provides strategies for early prevention. The study ... ,Cleft lip/palate is the most common congenital ... Patients with cleft conditions generally display poorer oral ...
... times are over for those who prefer relaxing with a ... study conducted by researchers from Charite Hospital Universitatsmedizin in Berlin, ... out with a study that shows adding milk to your ... ,Tea is known to contain flavonoids like catechins, ...
Cached Medicine News:Health News:Avian Nightmare 2
(Date:3/3/2015)... , March 3, 2015 Depomed, Inc. (NASDAQ: ... at the 27 th Annual Roth Conference in ... for 12:30 pm ET (9:30 am PT) Tuesday, March 10, 2015. ... webcast can be accessed via the Investor Relations page of ... the webcast will be archived for 30 days on the ...
(Date:3/3/2015)... Denovo Biopharma, LLC, today announced that ... agonist), a late-stage neuroscience drug, from Eli Lilly ... rights to develop, manufacture and commercialize pomaglumetad globally, ... rights, data, and information. Lilly has an option ... for predetermined undisclosed financial terms.  ...
(Date:3/3/2015)... March 3, 2015  Blueprint Medicines today announced ... and commercialize novel drug candidates for an undisclosed ... a rare genetic disease. Blueprint Medicines will apply ... optimize drug candidates and will conduct all research ... New Drug (IND) application with the Food and ...
Breaking Medicine Technology:Depomed To Present At 27th Annual Roth Conference 2Denovo Biopharma Licenses Late-Stage Neuroscience Drug From Lilly For Development As A Personalized Medicine 2Blueprint Medicines Announces Strategic Collaboration with Alexion to Advance Kinase Drug Candidates in Rare Genetic Disease 2
... Medical Partners, the specialty pharmaceutical subsidiary of H. ... cold chain services agreement with Cardium Therapeutics (NYSE ... and regenerative medicine company, to support its recently ... professional-use, syringe-based wound care product used in the ...
... Care Corporation ("CompCare") (OTC BB: CHCR), a leading behavioral ... for managed care companies throughout the U.S., is pleased ... doubled to $71,210,000 compared to revenues of $35,214,000 in ... Chief Executive Officer said, "To continue our upward growth ...
Cached Medicine Technology:Smith Medical Partners Announces Logistics Agreement for Cardium's National Distribution of Excellagen™ 2Smith Medical Partners Announces Logistics Agreement for Cardium's National Distribution of Excellagen™ 3Comprehensive Care Corporation Doubles Its 2011 Revenues to Over $71 Million 2Comprehensive Care Corporation Doubles Its 2011 Revenues to Over $71 Million 3
... (1.5x) Gonio lens will enable visualization of ... mirror lens is the industry preferred standard ... features : , Crispest, clearest imaging ... unattainable with Gonio lenses., 4 equally angled ...
... alternative to bulky biometry devices that have ... AP2000 is the world's only battery-operated, fully ... the market today. Each unit weighs a ... perform multiple functions, namely: auto data capture, ...
... The PiGalileo™ ... System from PLUS ... Surgery technology and ... technologies to assist ...
... a low TLR (<1%) and stroke rate ... and long-term durability., , , High Radial ... carotid artery, increasing lumen diameter with chronic ... Minimal stent shortening, low profile design, Cordis ...
Medicine Products: